Overexpression of functional human FLT3 ligand in Pichia pastoris

被引:0
|
作者
E. Karimi
H. Faraji
D. Hamidi Alamdari
M. Souktanloo
M. Mojarrad
L. K. Ashman
B. Mashkani
机构
[1] Mashhad University of Medical Sciences,Department of Medical Biochemistry, School of Medicine
[2] Mashhad University of Medical Sciences,Department of Medical Biotechnology, School of Medicine
[3] Mashhad University of Medical Sciences,Department of Medical Genetics, School of Medicine
[4] University of Newcastle,Department of Medical Biochemistry, School of Biomedical Sciences and Pharmacy
[5] Hormozgan University of Medical Sciences,Department of Laboratory Sciences, Faculty of Paramedicine
来源
关键词
recombinant protein production; codon optimization; biological activity; FLT3 ligand; methanol induction;
D O I
暂无
中图分类号
学科分类号
摘要
Growth factors and cytokines including FLT3 Ligand (FLT3L) have many applications in cellular and molecular biology studies, and also as therapeutical agents. FLT3L was expressed in Pichia pastoris through cloning from human leukemic K562 cell line as well as using a codon-optimized synthetic construct. Codon adaptation index (CAI) was increased from 55 in the native sequence up to 95 after optimization. Significant changes occurred in the codons for Pro, Arg, Leu and Ser toward the favored codons in P. pastoris. Both forms of expressed FLT3L (from the native and optimized sequences) were capable of stimulating proliferation of the FDC-P1 cells expressing human wild-type FLT3 (FD–FLT3–WT). Sequence optimization resulted in 55-fold increase in the yield of active FLT3L (290 μg/mL of product in the crude supernatant). Amino acid residues 27–162 are sufficient for the biological function of human FLT3L. Pichia pastoris is a highly efficient and cost-effective system for expression of endotoxin-free FLT3L; however, codon optimization is necessary for its optimal expression.
引用
收藏
页码:421 / 428
页数:7
相关论文
共 50 条
  • [21] Attenuation of vaccinia virus by the expression of human Flt3 ligand
    Zurkova, Kamila
    Hainz, Petr
    Krystofova, Jitka
    Kutinova, Luda
    Sanda, Miloslav
    Nemeckova, Sarka
    VIROLOGY JOURNAL, 2010, 7
  • [22] Structure function studies of human FLT3 ligand.
    Escobar, S
    Brasel, K
    Anderberg, R
    Lyman, SD
    BLOOD, 1995, 86 (10) : 74 - 74
  • [23] In vivo effects of flt3 ligand
    Williams, DE
    BLOOD, 1997, 90 (12) : 5022 - 5022
  • [24] Biological activities of FLT3 ligand
    Lyman, SD
    Brasel, K
    Maraskovsky, E
    Miller, RE
    Schuh, J
    Maliszewski, C
    Pulendran, B
    Stocking, K
    Peschon, J
    Lynch, D
    McKenna, H
    EXPERIMENTAL HEMATOLOGY, 1997, 25 (08) : 7 - 7
  • [25] BIOLOGY OF FLT3 LIGAND AND RECEPTOR
    LYMAN, SD
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 1995, 62 (02) : 63 - 73
  • [26] Effects of dexamethasone on Flt3 receptor expression and proliferation induced by recombinant human Flt3 ligand in malignant hematopoietic cells
    Xu, ZX
    Xu, Y
    Zhu, JK
    Li, CX
    Li, Y
    Zhang, XG
    ACTA PHARMACOLOGICA SINICA, 2001, 22 (06) : 534 - 540
  • [27] Glycofrom organization of a recombinant human growth factor, Flt3 ligand
    Wang, W
    Koffley, C
    Gombotz, W
    GLYCOBIOLOGY, 1999, 9 (10) : 1149 - 1149
  • [28] Detection of the FLT3 ligand and receptor in human microvascular endothelial cells
    Chen, HH
    Dosanjh, A
    Naghshineh, S
    Karasek, M
    MOLECULAR BIOLOGY OF THE CELL, 2000, 11 : 232A - 232A
  • [29] MODULATION OF HEMATOPOIETIC PROGENITOR DEVELOPMENT BY RECOMBINANT HUMAN FLT3 LIGAND
    BANU, N
    DENG, B
    LYMAN, S
    GROOPMAN, JE
    AVRAHAM, H
    BLOOD, 1994, 84 (10) : A269 - A269
  • [30] In vivo generation of human dendritic cell subsets by Flt3 ligand
    Maraskovsky, E
    Daro, E
    Roux, E
    Teepe, M
    Maliszewski, CR
    Hoek, J
    Caron, D
    Lebsack, ME
    McKenna, HJ
    BLOOD, 2000, 96 (03) : 878 - 884